. 2017 May 23;55(6):1812–1820. doi: 10.1128/JCM.02524-16

TABLE 2.

Yeast phase MIC distribution of 50 E. africanus clinical isolates

Antifungal agent	Test method	No. of isolates with MIC (mg/liter) of:														GM MIC^a	MIC₅₀^a	MIC₉₀^a	MIC range^a
Antifungal agent	Test method	≤0.008	0.015	0.03	0.06	0.12	0.25	0.5	1	2	4	8	16	32	≥64	GM MIC^a	MIC₅₀^a	MIC₉₀^a	MIC range^a
Itraconazole	BMD	36	5	4		5										0.01	0.008	0.008	0.008–0.12
Voriconazole	BMD	45	5													0.01	0.008	0.015	0.008–0.015
Posaconazole	BMD	37	6	3	1	2	1									0.01	0.008	0.03	0.008–0.25
Fluconazole	BMD					28	11	10	1							0.18	0.12	0.5	0.12–1
Caspofungin	BMD				1	1	2	2	25	10	7	2				1.18	1	4	0.06–8
Micafungin	BMD					1	4	1	11	15	9	9				1.85	2	8	0.12–8
Anidulafungin	BMD					1	1		20	24	3	1				1.34	2	2	0.12–8
Flucytosine	BMD										1	1	1	1	46	171.74	256	256	4–256
Amphotericin B	Etest	13	1	7	11	7	9	1	1							0.03	0.06	0.25	0.002–1
Itraconazole	Etest	35	5	6	1		3									0.01	0.008	0.03	0.002–0.25
Voriconazole	Etest	49	1													0.001	0.002	0.002	0.002–0.012
Posaconazole	Etest	49	1													0.002	0.002	0.006	0.002–0.012

All MICs are in milligrams per milliliter.